VANCOUVER, British Columbia, June 29, 2018 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc.(CSE:RQB) (OTCQB:RVVQF) (Frankfurt:1IT) (the “Company” or “RavenQuest”) is pleased to announce it will hold a media and investor open house at its Alberta Green Biotech facility, located in Edmonton, Alberta, on Monday, July 9th at 11:00 a.m. Media and investors are encouraged to contact the Company using the information below should they wish to attend. Wine, cheese and lunch will be served.
During the event, RavenQuest will unveil its Orbital Garden technology, “OG 2.0”, which will revolutionize cannabis production. Under RavenQuest’s design Orbital Gardens are stacked three high and two wide, allowing for 500 square feet of grow space inside a 64 square foot footprint, dramatically changing the conversation around square footage as it pertains to cannabis production.
RavenQuest CEO, George Robinson, remarked “As we near completion of Alberta Green Biotech, installation of the OG 2.0 systems into the grow rooms has begun. We are excited to reveal this paradigm shift to the public because it’s so much more than a story of dollars and cents. Certainly, our gardens’ productivity will be more than twice the industry average, will use 80% less power and 50% less water than the old-fashioned “flat table” growing environments. But we believe the real story here is sustainability. Industry wide, Canadian companies are going to be growing a lot of cannabis. With this kind of scale, it’s important we conduct ourselves responsibly and care for the environment”.
“RavenQuest believes strongly in the science of the plant and believes strongly in environmental stewardship. We believe our patients and clients want to see this kind of social responsibility in the products and brands they consume” Robinson continued.
About RavenQuest BioMed Inc.
RavenQuest BioMed Inc. is a diversified publicly traded cannabis company with divisions focused upon cannabis production, management services & consulting and specialized research & development.
RavenQuest is a licensed producer with facilities located in Markham, Ontario and Edmonton, Alberta, whose combined annual production will total 11,000 kg beginning in late 2018.
RavenQuest maintains a research partnership with Montreal's McGill University focussed upon cultivar (strain) recognition, plant stabilization and yield maximization of the cannabis plant.
The Company focusses on partnerships with Indigenous communities and has announced an MOU to construct a 250,000 square foot cannabis production facility on sovereign land of Fort McMurray First Nation #468. The facility, using RavenQuest's revolutionary grow methodology, Orbital Garden 2.0, will produce 50,000 kg of cannabis annually.
RavenQuest has also recently announced an LOI to acquire Western Agripharma Ltd., a late stage application with a 125,000 square foot facility under construction on British Columbia's sunshine coast, a short ferry ride from Vancouver, BC. Upon completion, the facility will produce 25,000 kg of cannabis annually.
On Behalf of the Board of Directors of
RAVENQUEST BIOMED INC.
Chief Executive Officer
|For further information, please contact:||Mathieu McDonald, Corporate Communications|
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this press release, which has been prepared by management.
Cautionary Note Regarding Forward-Looking Statements
All statements in this press release, other than statements of historical fact, are "forward-looking information" with respect to the Company within the meaning of applicable securities laws, including statements with respect to completion of the Company’s Alberta Green Biotech facility, and the installation of orbital garden systems. The Company provides forward-looking statements for the purpose of conveying information about current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. By its nature, this information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. These risks and uncertainties include but are not limited to those identified and reported in the Company’s public filings under the Company’s SEDAR profile at www.sedar.com. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise unless required by law.
© 2018 GlobeNewswire, Inc. All Rights Reserved.